FNDC5 and early-onset autosomal dominant Alzheimer disease: Recent research showed that the levels of FNDC5/irisin in cerebrospinal fluid and hippocampi were reduced in patients with Alzheimer’s disease and the mouse model of this chronic neurodegenerative disease.